AVH — AVITA Medical Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$391.45m
- AU$372.06m
- $50.14m
- 21
- 17
- 67
- 30
2020 June 30th | 2021 June 30th | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -42 | -26.6 | -26.7 | -35.4 |
Depreciation | ||||
Non-Cash Items | 17.5 | 7.32 | 8.2 | 3.31 |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 1.33 | -7.36 | -1.2 | -6.57 |
Change in Accounts Receivable | ||||
Change in Inventories | ||||
Change in Prepaid Expenses | ||||
Change in Other Assets | ||||
Change in Accrued Expenses | ||||
Change in Payable / Accrued Expenses | ||||
Change in Taxes Payable | ||||
Change in Other Liabilities | ||||
Cash from Operating Activities | -22.7 | -25.9 | -19.1 | -38 |
Capital Expenditures | -0.847 | -1.17 | -0.452 | -1.38 |
Purchase of Fixed Assets | ||||
Purchase / Acquisition of Intangibles | ||||
Other Investing Cash Flow Items | — | — | -18.9 | 2.99 |
Sale/Maturity of Investment | ||||
Purchase of Investments | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | -0.847 | -1.17 | -19.3 | 1.61 |
Financing Cash Flow Items | -5.08 | -5.11 | — | — |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 77.1 | 64 | 0.9 | 40.4 |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 53.5 | 37.1 | -37.5 | 3.95 |